Genetic testing proves important for identifying somatic and germline mutations in prostate cancer
As the role of genetic testing in clinical practice becomes more prevalent for prostate cancer patients to identify mutations, physicians must consider a variety of factors to determine which patients are candidates for somatic testing and /or germinal. As the role of genetic testing in clinical practice becomes more prevalent in patients with prostate cancer …